Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants
- PMID: 6189287
- DOI: 10.1016/0042-6822(83)90465-8
Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants
Abstract
Acid treatment of influenza A and B virus preparations followed by addition of dithiothreitol (DTT) and centrifugation through a sucrose cushion removes the HA1 subunit of hemagglutinin from virus. Rabbit sera made against these subviral particles and untreated virus were tested in a radioimmune precipitation assay using [35S]cysteine-labeled virus. Conditions of the assay permitted discrimination of discrete HA1- and HA2-specific antibody populations. It was found that (a) sera raised to intact influenza A virus preparations contained both HA1- and HA-2 specific antibodies, (b) sera made to subviral particles of influenza A virus contained HA2-specific antibody but had little or no detectable HA1-specific antibody. (c) the HA2-specific antibodies were partially cross-reactive with the HA2 of an influenza A virus of a different subtype, and (d) sera raised against two strains of untreated influenza B viruses contained antibodies which were cross-reactive with the HA2 as well as the NP of influenza A viruses.
Similar articles
-
HA2 glycopolypeptide of influenza A virus and antiviral immunity.Acta Virol. 2013;57(2):247-56. doi: 10.4149/av_2013_02_247. Acta Virol. 2013. PMID: 23600881 Review.
-
Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits.Arch Virol. 1987;97(3-4):251-65. doi: 10.1007/BF01314425. Arch Virol. 1987. PMID: 3322235
-
Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.Acta Virol. 1987 Sep;31(5):374-86. Acta Virol. 1987. PMID: 2891276
-
The influenza virus-infected host cell, a target for the immune response.Behring Inst Mitt. 1991 Jul;(89):1-11. Behring Inst Mitt. 1991. PMID: 1930089 Review.
-
Immunological studies with the HA1 and HA2 polypeptides of influenza A virus haemagglutinin.Exp Cell Biol. 1978;46(6):338-54. doi: 10.1159/000162910. Exp Cell Biol. 1978. PMID: 81152
Cited by
-
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.Emerg Microbes Infect. 2023 Dec;12(1):2192821. doi: 10.1080/22221751.2023.2192821. Emerg Microbes Infect. 2023. PMID: 36927227 Free PMC article.
-
SARS-CoV-2 epitopes inform future vaccination strategies.Front Immunol. 2022 Nov 25;13:1041185. doi: 10.3389/fimmu.2022.1041185. eCollection 2022. Front Immunol. 2022. PMID: 36505475 Free PMC article. Review.
-
Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines.Front Immunol. 2022 Sep 20;13:952650. doi: 10.3389/fimmu.2022.952650. eCollection 2022. Front Immunol. 2022. PMID: 36203593 Free PMC article.
-
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China.Life (Basel). 2022 Aug 27;12(9):1326. doi: 10.3390/life12091326. Life (Basel). 2022. PMID: 36143363 Free PMC article. Review.
-
Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.Comput Struct Biotechnol J. 2022;20:3533-3544. doi: 10.1016/j.csbj.2022.06.043. Epub 2022 Jun 23. Comput Struct Biotechnol J. 2022. PMID: 35765543 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous